Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 1
1916 2
1921 1
1924 1
1927 1
1928 1
1929 1
1945 1
1946 1
1947 3
1951 1
1952 1
1954 1
1955 2
1957 5
1958 3
1959 4
1960 1
1961 2
1962 5
1963 3
1964 3
1965 6
1966 10
1967 15
1968 8
1969 11
1970 21
1971 7
1972 10
1973 13
1974 16
1975 14
1976 17
1977 16
1978 12
1979 13
1980 10
1981 16
1982 22
1983 33
1984 20
1985 31
1986 18
1987 22
1988 30
1989 40
1990 34
1991 47
1992 42
1993 33
1994 47
1995 52
1996 35
1997 66
1998 51
1999 61
2000 81
2001 70
2002 85
2003 73
2004 81
2005 91
2006 114
2007 113
2008 130
2009 124
2010 126
2011 159
2012 142
2013 158
2014 166
2015 156
2016 172
2017 147
2018 160
2019 166
2020 145
2021 188
2022 186
2023 176
2024 163
2025 107

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,046 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for richardson d
Search for Richardso D instead (1 results)
Ionising radiation and cardiovascular disease: systematic review and meta-analysis.
Little MP, Azizova TV, Richardson DB, Tapio S, Bernier MO, Kreuzer M, Cucinotta FA, Bazyka D, Chumak V, Ivanov VK, Veiga LHS, Livinski A, Abalo K, Zablotska LB, Einstein AJ, Hamada N. Little MP, et al. Among authors: richardson db. BMJ. 2023 Mar 8;380:e072924. doi: 10.1136/bmj-2022-072924. BMJ. 2023. PMID: 36889791 Free PMC article.
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
Vergote I, Pérez-Fidalgo JA, Hamilton EP, Valabrega G, Van Gorp T, Sehouli J, Cibula D, Levy T, Welch S, Richardson DL, Guerra EM, Scambia G, Henry S, Wimberger P, Miller DS, Klat J, Martínez-Garcia J, Raspagliesi F, Pothuri B, Romero I, Bergamini A, Slomovitz B, Schochter F, Høgdall E, Fariñas-Madrid L, Monk BJ, Michel D, Kauffman MG, Shacham S, Mirza MR, Makker V; ENGOT-EN5/GOG-3055/SIENDO Investigators. Vergote I, et al. Among authors: richardson dl. J Clin Oncol. 2023 Dec 10;41(35):5400-5410. doi: 10.1200/JCO.22.02906. Epub 2023 Sep 5. J Clin Oncol. 2023. PMID: 37669480 Clinical Trial.
Seeing the PDB.
Richardson JS, Richardson DC, Goodsell DS. Richardson JS, et al. Among authors: richardson dc. J Biol Chem. 2021 Jan-Jun;296:100742. doi: 10.1016/j.jbc.2021.100742. Epub 2021 May 4. J Biol Chem. 2021. PMID: 33957126 Free PMC article. Review.
Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis.
Todhunter-Brown A, Booth L, Campbell P, Cheer B, Cowie J, Elders A, Hagen S, Jankulak K, Mason H, Millington C, Ogden M, Paterson C, Richardson D, Smith D, Sutcliffe J, Thomson K, Torrens C, McClurg D. Todhunter-Brown A, et al. Among authors: richardson d. Health Technol Assess. 2024 Jan;28(5):1-266. doi: 10.3310/PLTR9622. Health Technol Assess. 2024. PMID: 38343084 Free PMC article.
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.
Richardson DL, Moore KN, Vergote I, Gilbert L, Martin LP, Mantia-Smaldone GM, Castro CM, Provencher D, Matulonis UA, Stec J, Wang Y, Method M, O'Malley DM. Richardson DL, et al. Gynecol Oncol. 2024 Jun;185:186-193. doi: 10.1016/j.ygyno.2024.01.045. Epub 2024 Mar 5. Gynecol Oncol. 2024. PMID: 38447347 Free article. Clinical Trial.
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice.
Richardson DL, Quintanilha JCF, Danziger N, Li G, Sokol E, Schrock AB, Ebot E, Bhardwaj N, Norris T, Afghahi A, Frachioni A, Washington C, Dockery L, Elvin J, Graf RP, Moore KN. Richardson DL, et al. Clin Cancer Res. 2024 Oct 15;30(20):4644-4653. doi: 10.1158/1078-0432.CCR-24-1225. Clin Cancer Res. 2024. PMID: 39078736 Free PMC article.
Joint action aesthetics.
Vicary S, Sperling M, von Zimmermann J, Richardson DC, Orgs G. Vicary S, et al. Among authors: richardson dc. PLoS One. 2017 Jul 25;12(7):e0180101. doi: 10.1371/journal.pone.0180101. eCollection 2017. PLoS One. 2017. PMID: 28742849 Free PMC article.
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.
Holloway RW, Thaker P, Mendivil AA, Ahmad S, Al-Niaimi AN, Barter J, Beck T, Chambers SK, Coleman RL, Crafton SM, Crane E, Ramez E, Ghamande S, Graybill W, Herzog T, Indermaur MD, John VS, Landrum L, Lim PC, Lucci JA, McHale M, Monk BJ, Moore KN, Morris R, O'Malley DM, Reid TJ, Richardson D, Rose PG, Scalici JM, Silasi DA, Tewari K, Wang EW. Holloway RW, et al. Among authors: richardson d. Int J Gynecol Cancer. 2023 Sep 4;33(9):1458-1463. doi: 10.1136/ijgc-2023-004812. Int J Gynecol Cancer. 2023. PMID: 37666539 Free article. Clinical Trial.
4,046 results